Market Research Reports and Industry Reports

Anacor Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Anacor Pharmaceuticals Inc (Anacor) is a biopharmaceutical company that discovers, develops and markets small molecule therapeutics based on its boron chemistry platform. The companys marketed products include a topical solution which is an oxaborole antifungal that is used for the topical treatment of onychomycosis of the toenails. Its lead pipeline candidates encompass a non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor for the treatment of mild-to-moderate atopic dermatitis and psoriasis; and an antibiotic for the potential treatment of infections caused from gram-negative bacteria. Anacors boron chemistry platform is used to treat diseases in animals caused due to bacteria, fungi and parasites. It out-licensed three investigational compounds: indication targeted at the treatment of an animal health to Eli Lilly and Company; indication for the treatment of human African trypanosomiasis to Drugs for Neglected Diseases; and indication targeted at the treatment of tuberculosis to GlaxoSmithKline LLC. Anacor is headquartered in Palo Alto, California, the US.

Anacor Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

3
List of Tables 4
List of Figures 4
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Anacor Pharma Amends Co-Marketing Agreement with Sandoz for Kerydin 10
Anacor Pharma Amends Research Agreement With Bill & Melinda Gates Foundation 12
Equity Offering 13
Anacor Pharma Files Registration Statement For Public Offering Of Securities For Up To US$50 Million 13
Anacor Pharma Completes Public Offering Of Common Stock For US$23 Million 14
Anacor Pharma Completes Public Offering Of Common Stock For US$24 Million 15
Anacor Pharma Completes Public Offering Of Common Stock For US$21.5 Million 16
Debt Offering 18
Anacor Pharma Raises USD287.5 Million in Private Placement of 2% Notes Due 2023 18
Anacor Pharma Raises USD82.5 Million Private Placement of Notes Due 2021 20
Anacor Pharma Raises USD8 Million in Private Placement of Notes Due 2021 22
Acquisition 24
Pfizer Acquires Anacor Pharma for USD5.2 Billion 24
Anacor Pharmaceuticals Inc - Key Competitors 26
Anacor Pharmaceuticals Inc - Key Employees 27
Anacor Pharmaceuticals Inc - Locations And Subsidiaries 28
Head Office 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List Of Tables


Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anacor Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anacor Pharma Amends Co-Marketing Agreement with Sandoz for Kerydin 10
Anacor Pharma Amends Research Agreement With Bill & Melinda Gates Foundation 12
Anacor Pharma Files Registration Statement For Public Offering Of Securities For Up To US$50 Million 13
Anacor Pharma Completes Public Offering Of Common Stock For US$23 Million 14
Anacor Pharma Completes Public Offering Of Common Stock For US$24 Million 15
Anacor Pharma Completes Public Offering Of Common Stock For US$21.5 Million 16
Anacor Pharma Raises USD287.5 Million in Private Placement of 2% Notes Due 2023 18
Anacor Pharma Raises USD82.5 Million Private Placement of Notes Due 2021 20
Anacor Pharma Raises USD8 Million in Private Placement of Notes Due 2021 22
Pfizer Acquires Anacor Pharma for USD5.2 Billion 24
Anacor Pharmaceuticals Inc, Key Competitors 26
Anacor Pharmaceuticals Inc, Key Employees 27

List Of Figures


Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anacor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

ADIF – Enllaç to Manacor Stations Electrification – Balearic Islands - Project Profile

Synopsis ADIF Enlla to Manacor Stations Electrification Balearic Islands - Project Profile contains information on the scope of the project including project overview and location. The profile also details

USD 75View Report

Andeavor – Anacortes Xylene Processing Facility Upgrade – Washington - Project Profile

Synopsis Andeavor Anacortes Xylene Processing Facility Upgrade Washington - Project Profile contains information on the scope of the project including project overview and location. The profile also details project

USD 75View Report

Sienna Biopharmaceuticals Inc (SNNA) - Medical Equipment - Deals and Alliances Profile

Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a biopharmaceutical company that develops innovation therapies for inflammatory skin conditions and aesthetic conditions. It offers topical by design or low systemic exposure technology

USD 250View Report

Syndax Pharmaceuticals Inc (SNDX) - Medical Equipment - Deals and Alliances Profile

Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The companys lead product candidate, entinostat, an oral, small molecule drug

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Jan 2018
No. of Pages :29
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 
istanbul escort istanbul escort istanbul escort izmit escort eskisehir escort samsun escort bursa escort ankara escort konya escort adana escort gaziantep escort kayseri escort izmir escort hatay escort

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
maltepe escort kartal escort manavgat escort manavgat side escort konya escort tuzla escort pendik escort maltepe escort maltepe escort porno